Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
about
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study.Clinical relevance of P-glycoprotein in drug therapy.Atazanavir for the treatment of human immunodeficiency virus infection.Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration.HIV pharmacology: barriers to the eradication of HIV from the CNS.Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationAntiretroviral bioanalysis methods of tissues and body biofluids.Drug interactions at the blood-brain barrier: fact or fantasy?How much do antiretroviral drugs penetrate into the central nervous system?CSF penetration by antiretroviral drugs.Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.Lopinavir cerebrospinal fluid steady-state trough concentrations in HIV-infected adults.
P2860
Q34202181-3B43DF83-4167-4F59-B7E1-DF6C2789C3FAQ34309626-13F36A57-1CB8-4E7F-875C-466FD219219DQ35070434-74968E52-F9BF-43BE-85E7-9758C7528C28Q35620664-6B7DD3CA-B96C-4050-9261-1E0C97BCF5ECQ35976835-44AF7F02-230D-431D-A9B4-A382BCAB9F7CQ36266689-43117170-DA30-4112-9916-7E226D008267Q36552753-9E78A661-0430-4A84-91DC-02CC9A1C04CEQ36593671-D8CDB63F-8D61-47B3-9DAC-94BCE5DA8DB0Q37332868-5497115B-F339-4432-82C4-EFA60330A54BQ37362486-AB3506EE-D17A-4717-B485-FD811357C463Q38003612-0BCC1B7A-3148-494C-9EDB-D154D2EE0C77Q38060571-0CCCF404-84FB-4837-9259-823933DB6B1FQ41208022-377C7C37-4DC3-439C-A30E-0879E9B32F31Q42640557-E31E2A9E-38D6-4E68-9950-B96A9A660F27
P2860
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@ast
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@en
type
label
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@ast
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@en
prefLabel
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@ast
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@en
P2093
P2860
P1476
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
@en
P2093
Alfred J Saah
Benjamin Johnson
David W Haas
Farideh B Bowles
Janet Nicotera
Jennifer Schranz
Julie Stone
Stephen Raffanti
Tyler S Finn
Vicki L Bailey
P2860
P304
P356
10.1128/AAC.47.7.2131-2137.2003
P407
P577
2003-07-01T00:00:00Z